BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

4:04 PM
 | 
Aug 22, 2007
 |  BC Extra  |  Top Story

Nuvelo up after restarting SONOMA-3

NUVO gained $0.27 (17%) to $1.90 on Wednesday after it restarted the SONOMA-3 trial of alfimeprase in up to 100 patients with venous catheter occlusion (CO). In December, NUVO and Bayer (FSE:BAY; BAY) suspended enrollment...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >